Global Forum of the World Federation of Hemophilia, September 26-27, 2005, Montreal, Quebec, Canada
Transfus Apher Sci
.
2006 Oct;35(2):151-172.
doi: 10.1016/j.transci.2006.07.003.
Epub 2006 Nov 7.
Authors
M Skinner Mr
1
,
P M Mannucci Dr
2
,
A Farrugia Prof
3
,
D DiMichele Dr
4
,
P Bolton-Maggs Dr
5
,
T Burnouf Dr
6
,
G Sher Dr
7
,
D Armstrong Dr
8
,
G Rock Dr
9
,
A Farrugia Prof
3
,
T Barrowcliffe Dr
10
,
J Dodt Dr
11
,
M Soucie Dr
12
,
C Bryant Dr
13
,
B Chiasson Dr
14
,
M Weinstein Dr
4
,
D Page Mr
15
,
B O'Mahony Mr
16
,
J Bult Mr
17
,
P Bolton-Maggs Dr
5
,
S Rezende Dr
18
,
M Brooker Mr
1
,
N Dhingra Dr
19
,
C Black Ms
1
Affiliations
1
World Federation of Hemophilia.
2
A. Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
3
Australian Therapeutic Goods Administration.
4
Food and Drug Administration, United States.
5
Manchester Royal Infirmary, United Kingdom.
6
Human Plasma Product services, Lille, France.
7
Canadian Blood Services.
8
Natal BioProducts Institute, South Africa.
9
University of Ottawa, Canada.
10
National Institute for Biological Standards and Control, United Kingdom.
11
Paul Ehrlich Institute, Germany.
12
Centers for Disease Control and Prevention, United States.
13
Plasma Protein Purification System.
14
Bayer Healthcare, Biological Products, Canada.
15
Canadian Hemophilia Society.
16
Irish Haemophilia Society.
17
Plasma Proteins Therapeutics Association.
18
Brazilian Ministry of Health.
19
World Health Organization, Geneva.
PMID:
28356214
DOI:
10.1016/j.transci.2006.07.003
No abstract available